Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease Patients
Clinical trial NCT06408935 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06408935
- Sponsor
- Janssen-Cilag Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-17
- Primary completion
- 2027-06-08
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.